Molecular mechanisms and clinical applications of gut microbiota-derived bioactive compounds in metabolic dysfunction-associated fatty liver disease

Metabolic (dysfunction)-associated fatty liver disease (MAFLD) has emerged as a leading cause of chronic liver disease worldwide. Its pathogenesis is closely associated with gut microbiota dysbiosis and metabolic disturbances. In recent years, numerous studies have demonstrated that bioactive compou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chengyun Ma, Jing Wang, Xuanli Song, Xue Wang, Shuai Zong
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2025-10-01
Colección:Frontiers in Immunology
Materias:
metabolic dysfunction-associated fatty liver disease
gut microbiota-derived bioactive compound
microbiota-host crosstalk
pathogenesis
clinical application
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1682755/full
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares